These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22522911)

  • 1. Silencing of Wnt5a during colon cancer metastasis involves histone modifications.
    Li Q; Chen H
    Epigenetics; 2012 Jun; 7(6):551-8. PubMed ID: 22522911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional silencing of N-Myc downstream-regulated gene 1 (NDRG1) in metastatic colon cancer cell line SW620.
    Li Q; Chen H
    Clin Exp Metastasis; 2011 Feb; 28(2):127-35. PubMed ID: 21184144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development.
    Zhang Y; Li Q; Chen H
    Carcinogenesis; 2013 Aug; 34(8):1756-63. PubMed ID: 23598468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
    Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
    Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines.
    Ikehata M; Ueda K; Iwakawa S
    Biol Pharm Bull; 2012; 35(3):301-7. PubMed ID: 22382314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.
    Kawamoto K; Hirata H; Kikuno N; Tanaka Y; Nakagawa M; Dahiya R
    Int J Cancer; 2008 Aug; 123(3):535-42. PubMed ID: 18404682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase expression is associated with histone modifications in glioblastoma.
    Hong X; Nelson K; Lemke N; Kalkanis SN
    Int J Oncol; 2012 Feb; 40(2):494-500. PubMed ID: 22001963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid limitation induces down-regulation of WNT5a at transcriptional level.
    Wang Z; Chen H
    Biochem Biophys Res Commun; 2009 Jan; 378(4):789-94. PubMed ID: 19063862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines.
    Liu Y; Hong Y; Zhao Y; Ismail TM; Wong Y; Eu KW
    Cancer Invest; 2008 Jul; 26(6):575-82. PubMed ID: 18584348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
    Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
    J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.
    Fahrner JA; Eguchi S; Herman JG; Baylin SB
    Cancer Res; 2002 Dec; 62(24):7213-8. PubMed ID: 12499261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation.
    Jensen TJ; Wozniak RJ; Eblin KE; Wnek SM; Gandolfi AJ; Futscher BW
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):39-46. PubMed ID: 19061910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.